Finance

Lists
054670:KOSDAQ
Daehan Nupharm Co Ltd
â‚©5,770.00
+0.35%
(+20.00) 1D
Aug 28, 3:30:30 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 054670...
Open
â‚©5,760
High
â‚©5,800
Low
â‚©5,700
Mkt. cap
82.83B
Avg. vol.
19.65K
Volume
4.94K
Dividend
1.73%
Quarterly dividend
â‚©25
Ex-dividend date
Dec 27, 2023
P/E ratio
3.38
52-wk high
â‚©7,900
52-wk low
â‚©5,030
EPS
â‚©1,705
Shares outstanding
14.35M
No. of employees
383
Open
â‚©5,760
High
â‚©5,800
Low
â‚©5,700
Mkt. cap
82.83B
Avg. vol.
19.65K
Volume
4.94K
Dividend
1.73%
Quarterly dividend
â‚©25
Ex-dividend date
Dec 27, 2023
P/E ratio
3.38
52-wk high
â‚©7,900
52-wk low
â‚©5,030
EPS
â‚©1,705
Shares outstanding
14.35M
No. of employees
383
About Daehan Nupharm Co Ltd
CEO-
Employees383
Founded1984
Headquarters-
SectorPharmaceutical industry
Websitedhnp.co.kr
Previous reportsAll values in KRW
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in KRW
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
48.88B
51.79B
54.84B
55.97B
Cost of goods sold
26.80B
30.63B
31.79B
33.33B
Cost of revenue
26.80B
30.63B
31.79B
33.33B
Research and development expenses
2.27B
1.11B
2.35B
2.07B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
17.06B
17.94B
17.15B
18.12B
Operating expense
20.00B
18.82B
19.92B
20.49B
Total operating expenses
46.80B
49.45B
51.71B
53.82B
Operating income
2.08B
2.34B
3.14B
2.15B
Other non operating income
66.14M
662.78M
-67.89M
49.93M
EBT including unusual items
3.36B
4.42B
3.53B
14.52B
EBT excluding unusual items
1.72B
2.41B
2.42B
1.74B
Income tax expense
750.00M
-2.65B
531.04M
3.26B
Effective tax rate
22.33%
-59.91%
15.05%
22.45%
Other operating expenses
219.42M
174.10M
331.19M
138.55M
Net income
2.61B
7.06B
3.00B
11.26B
Net profit margin
5.34%
13.64%
5.47%
20.13%
Earnings per share
-
-
-
-
Interest and investment income
56.87M
63.85M
48.89M
98.21M
Interest expense
-338.10M
-509.73M
-487.74M
-449.82M
Net interest expenses
-281.24M
-445.88M
-438.86M
-351.60M
Depreciation and amortization charges
472.58M
-113.13M
303.00M
296.62M
EBITDA
3.16B
3.44B
4.25B
3.62B
Gain or loss from assets sale
3.00K
289.84M
372.00K
-
AI content may include mistakes. Learn more
AI content may include mistakes. Learn more
Google apps